Literature DB >> 15816955

Can you predict an immediate, complete, and sustained response to the ketogenic diet?

Khoi D Than1, Eric H Kossoff, James E Rubenstein, Paula L Pyzik, Jane R McGrogan, Eileen P G Vining.   

Abstract

PURPOSE: Although the ketogenic diet has been in use for >80 years, little agreement exists as to which patients are most likely to have dramatic, sudden, and complete seizure control.
METHODS: A case-control study was performed of children with intractable epilepsy started on the ketogenic diet at our institution since June 2001. Patients with a dramatic response were defined as those becoming seizure free within 2 weeks of diet onset. These children were compared with all other patients treated with the diet over the same time period in terms of patient demographics, epilepsy characteristics, and diet parameters.
RESULTS: Eighteen early, dramatic responders over a 3-year period were identified and compared with 89 patients who were not similarly improved. The absence of complex partial seizures as the predominant seizure type (0 vs. 23%; p = 0.02) correlated with this dramatic success. The presence of infantile spasms (39% vs. 20%; p = 0.09) approached significance, but all other variables did not.
CONCLUSIONS: An early, dramatic response to the ketogenic diet is more likely in patients with predominant seizure types other than complex partial. It may also be more likely to occur in children who have infantile spasms. In all other patient demographics and diet parameters, an equal likelihood of similar success was found.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816955     DOI: 10.1111/j.0013-9580.2005.53304.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

Review 1.  Dietary therapies for epilepsy: future research.

Authors:  Sudha K Kessler; Elizabeth G Neal; Carol S Camfield; Eric H Kossoff
Journal:  Epilepsy Behav       Date:  2011-03-26       Impact factor: 2.937

2.  Early EEG improvement after ketogenic diet initiation.

Authors:  Sudha Kilaru Kessler; Paul R Gallagher; Renée A Shellhaas; Robert R Clancy; A G Christina Bergqvist
Journal:  Epilepsy Res       Date:  2011-02-23       Impact factor: 3.045

Review 3.  Antiepileptic therapy in patients with central nervous system malignancies.

Authors:  Glen H J Stevens
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 4.  Does the effectiveness of the ketogenic diet in different epilepsies yield insights into its mechanisms?

Authors:  Adam L Hartman
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 5.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

Review 6.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

7.  Ketogenic diet: Predictors of seizure control.

Authors:  Nitin Agarwal; Dimitrios Arkilo; Osman Farooq; Cynthia Gillogly; Katelyn S Kavak; Arie Weinstock
Journal:  SAGE Open Med       Date:  2017-06-06

Review 8.  Metabolic Therapy for Temporal Lobe Epilepsy in a Dish: Investigating Mechanisms of Ketogenic Diet using Electrophysiological Recordings in Hippocampal Slices.

Authors:  Masahito Jr Kawamura; David N Ruskin; Susan A Masino
Journal:  Front Mol Neurosci       Date:  2016-11-01       Impact factor: 5.639

9.  The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disorders.

Authors:  Munhyang Lee
Journal:  Korean J Pediatr       Date:  2012-09-14

10.  Graph Theory-Based Electroencephalographic Connectivity and Its Association with Ketogenic Diet Effectiveness in Epileptic Children.

Authors:  Ting-Yu Su; Pi-Lien Hung; Chien Chen; Ying-Jui Lin; Syu-Jyun Peng
Journal:  Nutrients       Date:  2021-06-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.